A new analysis summarizes a decade of research on the effects of a psychedelic brew on anxiety and trauma responses. With the ...

One of these is the 5-HT2A receptor, which has a recently discovered unique characteristic: It dampens incoming visual information, giving our brain more space for internal processes and ...

Neushen Therapeutics Inc. has synthesized 5-HT2A receptor agonists reported to be useful for the treatment of depression, schizophrenia, anxiety and post-traumatic stress disorder.

New research explores how ayahuasca influences brain circuits involved in fear and anxiety, offering insights into its potential therapeutic uses ...

Explore ayahuasca's effects on anxiety, memory, and emotional processing, revealing its therapeutic potential for ...

As interest in psychedelic medicine grows, researchers have synthesized a decade of evidence to understand how ayahuasca ...

A comprehensive review published in Psychedelics examines the current understanding of how ayahuasca, a traditional Amazonian ...

The drug has shown strong results in phase 3 clinical trials, which are the basis for the new application to the FDA.

We propose a multi-site, double-blind, randomized clinical trial of the 5-HT2A receptor agonist psilocybin for smoking cessation. A diverse sample with regard to ethnoracial identity and SES will be ...